# Preliminary Efficacy, Safety and Pharmacokinetics Study of Nepadutant in Infant With Feeding Intolerance

> **NCT01532518** · PHASE2 · COMPLETED · sponsor: **Menarini Group** · enrollment: 27 (actual)

## Conditions studied

- Colic

## Interventions

- **DRUG:** Nepadutant

## Key facts

- **NCT ID:** NCT01532518
- **Lead sponsor:** Menarini Group
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2023-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01532518

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01532518, "Preliminary Efficacy, Safety and Pharmacokinetics Study of Nepadutant in Infant With Feeding Intolerance". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01532518. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*